# Safety and Efficacy of Subretinal Transplantation of Clinical Human Embryonic Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Retinitis Pigmentosa

> **NCT03944239** · PHASE1 · UNKNOWN · sponsor: **Qi Zhou** · enrollment: 10 (estimated)

## Conditions studied

- Retinitis Pigmentosa

## Interventions

- **BIOLOGICAL:** Retinal pigment epitheliums transplantation

## Key facts

- **NCT ID:** NCT03944239
- **Lead sponsor:** Qi Zhou
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05
- **Primary completion:** 2021-10
- **Final completion:** 2021-12
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2020-03-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03944239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03944239, "Safety and Efficacy of Subretinal Transplantation of Clinical Human Embryonic Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Retinitis Pigmentosa". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03944239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*